Marketplace Logo Donate

Daily business news and economic stories from Marketplace

Site funds study of brain tumor drug

Subscribe to our Newsletters

by Janet Babin

Pharmaceutical companies routinely spend more than $1 billion to bring a new drug to market. Drug patents help them recoup their investment — giving them a temporary monopoly.

But DCA is a cheap generic that’s been around for more than 30 years. The patent’s long gone. Companies have no economic incentive to study its potential to fight cancer.

So Dr. Evangelos Michelakis, a professor at the University of Alberta, set up a website to fund the research through public donations.

“We had people that sent a $10-dollar check and we had people that sent a $3,000 check — from Siberia, New Zealand, Africa, South America, the States,” says Dr. Michelakis.

Dr. Michelakis says donations paid for 90 percent of the study, which cost about $1 million. He’s asking the public to fund a second, larger clinical trial.

What's Next

Latest Episodes From Our Shows

Listen
4:33 PM PDT
28:34
Listen
4:21 PM PDT
27:06
Listen
1:37 PM PDT
1:50
Listen
7:37 AM PDT
6:54
Listen
Sep 27, 2022
7:59
Listen
Jul 7, 2022
30:13
Listen
Aug 9, 2022
24:46
Exit mobile version